[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@bio_clouseau Avatar @bio_clouseau M

M posts on X about $azn, $pfe, $gild, $lly the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks XXXX% currencies XXXX% finance XXXX% cryptocurrencies XXXX%

Social topic influence $azn #29, $pfe #202, $gild #19, $lly #15, $gmab #2, $jnj #7, $4507t 1.16%, $nvo 1.16%, $gsk 1.16%, $mgdl XXXX%

Top accounts mentioned or mentioned by @artsstocks @houndcl @learnbiotech @biopharmiq @biotechobserver @bambossie81 @adamfeuerstein @bertrandbio @bioinvestor24 @jacobplieth @pjamess69 @adamcancryn @gardnerlm @jq1234t @byjongardner @gcbioinv @applehelix @lifescivc @jonathanwosen @avidresearch

Top assets mentioned AstraZeneca PLC (AZN) Pfizer, Inc. (PFE) Gilead Sciences, Inc. (GILD) Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) Novo-Nordisk (NVO) GSK plc (GSK) AbbVie Inc (ABBV) Akropolis (AKRO) JUNO (JUNO) Merus N.V. Common Shares (MRUS) Merck & Co., Inc. (MRK) Bristol-Myers Squibb Co (BMY) Synthetify (SNY) Protagonist Therapeutics, Inc (PTGX) Prometheus Biosciences, Inc. Common Stock (RXDX) Tourmaline Bio, Inc. Common Stock (TRML) Cere Network (CERE) Metsera, Inc. Common Stock (MTSR)

Top Social Posts #

Top posts by engagements in the last XX hours

"$MGDL has moved up a 2ndry endpoint to a primary"
X Link @bio_clouseau 2022-05-09T10:39Z 20K followers, XX engagements

"What is track record of rumored deals on friday that didn't occur the following monday"
X Link @bio_clouseau 2025-10-13T11:39Z 20K followers, 8896 engagements

"Party X also interesting mention of "recent internal development""
X Link @bio_clouseau 2025-10-06T12:06Z 20K followers, 2613 engagements

"I think for me the most interesting part about the Peter Marks move is that $LLY now has an infectious disease focus. Unless immunology got mixed up with ID"
X Link @bio_clouseau 2025-10-07T18:07Z 20K followers, 7501 engagements

"$ABBV $GMAB Presentations from X folate targetting ADC's to be presented over next X weeks all with topo-1 1) $LLY LY4170156 @ ESMO 2) $AZN AZD5335 @ ESMO 3) $ZYME @ EORTC"
X Link @bio_clouseau 2025-10-14T10:25Z 20K followers, 4273 engagements

"$JNJ commentary on "speculative transactions""
X Link @bio_clouseau 2025-10-14T13:15Z 20K followers, 1991 engagements

"$PFE The shionogi submission suprisingly hasn't gotten much attention but their oral pill for Covid has its 1st US PDUFA next june for PEP"
X Link @bio_clouseau 2025-09-08T10:27Z 20K followers, 1671 engagements

"$AKRO $NVO premium with 5/19 considered market speculation start date. $GSK bought Boston on 5/14"
X Link @bio_clouseau 2025-10-09T10:23Z 20K followers, 3329 engagements

"Interesting timing with the Merck KgA and $GSK news"
X Link @bio_clouseau 2025-09-29T09:06Z 20K followers, 2077 engagements

"Has any biotech screwed up a windfall as $GLPG did. Managed to convince $GILD to pump billions into it in 2019 and wasted about half of that money amounting to 2-3B between then and now some of it in a cell therapy business that only a "limited" number of parties seem to want"
X Link @bio_clouseau 2025-10-02T10:21Z 20K followers, 5139 engagements

"Largest since $CELG for $JUNO acquisition i think. Next largest after $GMAB for $MRUS was maybe $GILD for $FTSV. Almost a handful of non oncology clinical stage acqusitions exceeding 8B since early 2018"
X Link @bio_clouseau 2025-09-29T15:55Z 20K followers, 3975 engagements

"$AZN $DSKNY Datroway met both PFS AND OS endpoints in Tropion-breast02 1st line IO ineligible TNBC P3 $GILD 20B ADC Trodelvy still waiting on OS in ASCENT-03"
X Link @bio_clouseau 2025-10-06T08:15Z 20K followers, 2663 engagements

"$MRK $BMY Interesting article on how lower doses of PD-1/PD-L1 might be as effective. Also impacts potential follow on s like the pd-1 bispecs"
X Link @bio_clouseau 2025-09-25T10:41Z 20K followers, 2862 engagements

"What does Stat sig mean in this context Is Akeso just looking at p0.05 or was there a pre defined value that wasn't affected by all the interim looks Isnt this final look going to affect Harmoni OS stat anyway Seems a meaningless point"
X Link @bio_clouseau 2025-08-27T11:39Z 20K followers, 8881 engagements

"Worth noting that Shionogi has submitted Ensitrelvir for prevention and PEP in US/EU and if there is any anti vaccine backlash that may be a cheaper preferred option rather than an LAAB from $IVVD or $AZN. Especially with covid variants rapidly changing"
X Link @bio_clouseau 2025-08-28T16:07Z 20K followers, 3770 engagements

"How was $IMRX able to raise XXX M including 25M from $SNY when ORR seems similar to gem+NabP Some questionable decisions on the oncology front from SNY"
X Link @bio_clouseau 2025-09-25T09:40Z 20K followers, 9179 engagements

"So doesnt look like the main event M&A wont happen today which likely means that $JNJ actually believes what it said below about $PTGX. Just wants the share of icotrokinra it doesnt own and ptgx thinks otherwise in terms of valuation"
X Link @bio_clouseau 2025-10-14T11:08Z 20K followers, 11.7K engagements

"Pretty decent track record for $PFE discards. $RXDX TL1A 11B $CERE neurology discards for 8.7B and now $TRML IL-6 for 1.4B. Impressive R&D team not so much the BD/outlicensing team"
X Link @bio_clouseau 2025-09-09T11:05Z 20K followers, 15.6K engagements

"Looks like $MTSR received a numerically better offer from a "party 1" but had to turn it down for regulatory + CVR timeline reasons. The former maybe implying that party X was perhaps $NVO $PFE"
X Link @bio_clouseau 2025-10-06T11:28Z 20K followers, 40.4K engagements